Clinical Trial Update: Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis [NA]

View source ↗

Summary

A completed clinical trial comparing Genoss DCB and SeQuent Please in Korean patients with coronary in-stent restenosis to evaluate safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• In-stent Restenosis

Drugs mentioned

• Genoss DCB (paclitaxel-coated balloon)
• SeQuent Please (paclitaxel-coated balloon)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED